Milestone Pharmaceuticals Ownership 2024 | Who Owns Milestone Pharmaceuticals Now?


OverviewForecastFinancialsChart

Institutional Ownership

60.13%

Insider Ownership

0.69%

Retail Ownership

39.18%

Institutional Holders

40.00

Milestone Pharmaceuticals Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKROCK INC.9.91%0.00%4,971,344--6,562,174Jun 30, 2024
RTW INVESTMENTS, LP6.49%0.07%3,256,102--4,298,055Jun 30, 2024
MILLENNIUM MANAGEMENT LLC5.48%0.00%2,749,930-105,682-3.70%3,657,407Jun 30, 2024
ALTA FUNDAMENTAL ADVISERS LLC5.30%1.11%2,658,589287,30012.12%3,509,337Jun 30, 2024
LION POINT CAPITAL, LP4.67%5.63%2,340,20740,0001.74%3,089,073Jun 30, 2024
ORBIMED ADVISORS LLC3.99%0.05%2,000,000--2,640,000Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC3.49%0.14%1,750,000--2,310,000Jun 30, 2024
GOLDMAN SACHS GROUP INC2.70%0.00%1,353,067--1,786,048Jun 30, 2024
BLEICHROEDER LP2.64%0.52%1,326,085--1,750,432Jun 30, 2024
STONEPINE CAPITAL MANAGEMENT, LLC2.47%1.50%1,239,199-223,097-15.26%1,635,743Jun 30, 2024
BML CAPITAL MANAGEMENT, LLC2.20%1.04%1,102,895496,75081.95%1,455,821Jun 30, 2024
ALTIUM CAPITAL MANAGEMENT LP2.02%0.55%1,012,368-200,514-16.53%1,336,326Jun 30, 2024
MORGAN STANLEY1.65%0.00%828,6548,8261.08%1,093,823Jun 30, 2024
IKARIAN CAPITAL, LLC0.93%0.11%466,019--619,806Jun 30, 2024
BOXER CAPITAL, LLC0.62%0.02%309,007--407,889Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.40%0.05%202,460--267,247Jun 30, 2024
ANCORA ADVISORS, LLC0.12%0.00%60,000--79,200Jun 30, 2024
ENVESTNET ASSET MANAGEMENT INC0.12%-59,5237,69014.84%78,570Jun 30, 2024
SQUAREPOINT OPS LLC0.11%0.00%54,68454,684100.00%72,730Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP0.08%-39,450--52,404Jun 30, 2024

Milestone Pharmaceuticals's largest institutional shareholder is BLACKROCK INC., holding 9.91% of the company's total share outstanding, currently valued at $6.56M. The top 10 institutional shareholders own together 47.14% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
LION POINT CAPITAL, LP4.67%5.63%2,340,20740,0001.74%3,089,073Jun 30, 2024
STONEPINE CAPITAL MANAGEMENT, LLC2.47%1.50%1,239,199-223,097-15.26%1,635,743Jun 30, 2024
ALTA FUNDAMENTAL ADVISERS LLC5.30%1.11%2,658,589287,30012.12%3,509,337Jun 30, 2024
BML CAPITAL MANAGEMENT, LLC2.20%1.04%1,102,895496,75081.95%1,455,821Jun 30, 2024
ALTIUM CAPITAL MANAGEMENT LP2.02%0.55%1,012,368-200,514-16.53%1,336,326Jun 30, 2024
BLEICHROEDER LP2.64%0.52%1,326,085--1,750,432Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC3.49%0.14%1,750,000--2,310,000Jun 30, 2024
IKARIAN CAPITAL, LLC0.93%0.11%466,019--619,806Jun 30, 2024
RTW INVESTMENTS, LP6.49%0.07%3,256,102--4,298,055Jun 30, 2024
ORBIMED ADVISORS LLC3.99%0.05%2,000,000--2,640,000Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.40%0.05%202,460--267,247Jun 30, 2024
BOXER CAPITAL, LLC0.62%0.02%309,007--407,889Jun 30, 2024
BETA WEALTH GROUP, INC.0.03%0.01%14,127--18,648Jun 30, 2024
CLEAR CREEK FINANCIAL MANAGEMENT, LLC0.04%0.00%19,500-5,500-22.00%25,740Jun 30, 2024
ANCORA ADVISORS, LLC0.12%0.00%60,000--79,200Jun 30, 2024
MILLENNIUM MANAGEMENT LLC5.48%0.00%2,749,930-105,682-3.70%3,657,407Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC0.06%0.00%30,779--40,628Jun 30, 2024
ATRIA INVESTMENTS, INC0.06%0.00%27,99127,991100.00%36,948Jun 30, 2024
VALEO FINANCIAL ADVISORS, LLC0.02%0.00%10,000--13,200Jun 30, 2024
GOLDMAN SACHS GROUP INC2.70%0.00%1,353,067--1,786,048Jun 30, 2024

The largest Milestone Pharmaceuticals shareholder by % of total assets is LION POINT CAPITAL, LP. The company owns 2.34M shares of Milestone Pharmaceuticals (MIST), representing 5.63% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BML CAPITAL MANAGEMENT, LLC2.20%1.04%1,102,895496,75081.95%1,455,821Jun 30, 2024
ALTA FUNDAMENTAL ADVISERS LLC5.30%1.11%2,658,589287,30012.12%3,509,337Jun 30, 2024
SQUAREPOINT OPS LLC0.11%0.00%54,68454,684100.00%72,730Jun 30, 2024
LION POINT CAPITAL, LP4.67%5.63%2,340,20740,0001.74%3,089,073Jun 30, 2024
ATRIA INVESTMENTS, INC0.06%0.00%27,99127,991100.00%36,948Jun 30, 2024
MORGAN STANLEY1.65%0.00%828,6548,8261.08%1,093,823Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC0.05%-24,6007,70045.56%32,718Jun 30, 2024
ENVESTNET ASSET MANAGEMENT INC0.12%-59,5237,69014.84%78,570Jun 30, 2024
SIMPLEX TRADING, LLC0.00%-1,1911,191100.00%1,000Jun 30, 2024
JONES FINANCIAL COMPANIES LLLP0.00%-1,0701,070100.00%1,412Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.01%-6,5005008.33%8,580Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.00%-194--258Jun 30, 2024
STATE STREET CORP0.04%-18,923--25,168,000Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.04%-17,576--23,376Jun 30, 2024
NATIONAL BANK OF CANADA /FI/0.01%-7,100--9,404Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP0.08%-39,450--52,404Jun 30, 2024
OLIVER LAGORE VANVALIN INVESTMENT GROUP0.00%-100--132Jun 30, 2024
FEDERATION DES CAISSES DESJARDINS DU QUEBEC0.02%0.00%10,500--13,860Jun 30, 2024
BLACKROCK INC.9.91%0.00%4,971,344--6,562,174Jun 30, 2024
GOLDMAN SACHS GROUP INC2.70%0.00%1,353,067--1,786,048Jun 30, 2024

As of Jun 30 2024, Milestone Pharmaceuticals's largest institutional buyer is BML CAPITAL MANAGEMENT, LLC. The company purchased 496.75K stocks of MIST, valued at $1.46M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VELAN CAPITAL INVESTMENT MANAGEMENT LP----650,000-100.00%-Jun 30, 2024
MONASHEE INVESTMENT MANAGEMENT LLC----500,000-100.00%-Jun 30, 2024
BANK OF MONTREAL /CAN/----273,100-100.00%-Jun 30, 2024
STONEPINE CAPITAL MANAGEMENT, LLC2.47%1.50%1,239,199-223,097-15.26%1,635,743Jun 30, 2024
ALTIUM CAPITAL MANAGEMENT LP2.02%0.55%1,012,368-200,514-16.53%1,336,326Jun 30, 2024
MILLENNIUM MANAGEMENT LLC5.48%0.00%2,749,930-105,682-3.70%3,657,407Jun 30, 2024
XTX TOPCO LTD----13,403-100.00%-Jun 30, 2024
CLEAR CREEK FINANCIAL MANAGEMENT, LLC0.04%0.00%19,500-5,500-22.00%25,740Jun 30, 2024
UBS GROUP AG----2,618-100.00%-Jun 30, 2024
NORTHERN TRUST CORP0.06%-27,784-532-1.88%36,674,000Jun 30, 2024
ICA GROUP WEALTH MANAGEMENT, LLC----200-100.00%-Jun 30, 2024
BLEICHROEDER LP2.64%0.52%1,326,085--1,750,432Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC3.49%0.14%1,750,000--2,310,000Jun 30, 2024
IKARIAN CAPITAL, LLC0.93%0.11%466,019--619,806Jun 30, 2024
RTW INVESTMENTS, LP6.49%0.07%3,256,102--4,298,055Jun 30, 2024
ORBIMED ADVISORS LLC3.99%0.05%2,000,000--2,640,000Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.40%0.05%202,460--267,247Jun 30, 2024
BOXER CAPITAL, LLC0.62%0.02%309,007--407,889Jun 30, 2024
BETA WEALTH GROUP, INC.0.03%0.01%14,127--18,648Jun 30, 2024
ANCORA ADVISORS, LLC0.12%0.00%60,000--79,200Jun 30, 2024

As of Jun 30 2024, Milestone Pharmaceuticals's biggest institutional seller is VELAN CAPITAL INVESTMENT MANAGEMENT LP. The company sold -0.65M shares of MIST, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SQUAREPOINT OPS LLC0.11%0.00%54,68454,684100.00%72,730Jun 30, 2024
ATRIA INVESTMENTS, INC0.06%0.00%27,99127,991100.00%36,948Jun 30, 2024
JONES FINANCIAL COMPANIES LLLP0.00%-1,0701,070100.00%1,412Jun 30, 2024

Milestone Pharmaceuticals's largest new institutional shareholder by number of shares is SQUAREPOINT OPS LLC, purchased 54.68K shares, valued at $72.73K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VELAN CAPITAL INVESTMENT MANAGEMENT LP----650,000-100.00%-Jun 30, 2024
MONASHEE INVESTMENT MANAGEMENT LLC----500,000-100.00%-Jun 30, 2024
BANK OF MONTREAL /CAN/----273,100-100.00%-Jun 30, 2024
XTX TOPCO LTD----13,403-100.00%-Jun 30, 2024
UBS GROUP AG----2,618-100.00%-Jun 30, 2024
ICA GROUP WEALTH MANAGEMENT, LLC----200-100.00%-Jun 30, 2024

Milestone Pharmaceuticals's largest sold out institutional shareholder by shares sold is VELAN CAPITAL INVESTMENT MANAGEMENT LP, sold -0.65M shares, valued at -, as of undefined.

Milestone Pharmaceuticals Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
TEKLA HEALTHCARE INVESTORS0.21%175,816--Mar 31, 2024
TEKLA LIFE SCIENCES INVESTORS0.16%77,794--Mar 31, 2024
T. Rowe Price Health Sciences Fund, Inc.0.07%227,013--Mar 31, 2024
BlackRock Credit Strategies Fund0.05%261,3441,2480.48%Mar 31, 2024
T. Rowe Price New Horizons Fund, Inc.0.03%171,156--Mar 31, 2024
T. Rowe Price Equity Series, Inc.0.01%8,832--Mar 31, 2024
FIDELITY SELECT PORTFOLIOS0.00%169,500--Feb 29, 2024
SPDR INDEX SHARES FUNDS0.00%18,923-2,688-12.44%Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%17,576--Feb 29, 2024
VALIC Co I0.00%24,122--Feb 29, 2024
Invesco Exchange-Traded Fund Trust II0.00%9,515--Jan 31, 2024
Voya MUTUAL FUNDS0.00%2,869--Jan 31, 2024
AIM INVESTMENT FUNDS (INVESCO INVESTMENT FUNDS)0.00%229,128--Jan 31, 2024
AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS)0.00%33,025--Mar 31, 2024
Blackstone Alternative Investment Funds0.00%600--Mar 31, 2024
EQ ADVISORS TRUST0.00%5,598--Mar 31, 2024
AMERICAN CENTURY ETF TRUST0.00%480--Feb 29, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%5,597--Mar 31, 2024
MASSMUTUAL SELECT FUNDS0.00%1,346--Dec 31, 2023
DFA INVESTMENT DIMENSIONS GROUP INC0.00%785-39,916-98.07%Jan 31, 2024
John Hancock Funds II0.00%9,082--Feb 29, 2024
MUTUAL FUND SERIES TRUST0.00%500--Mar 31, 2024

Milestone Pharmaceuticals's largest mutual fund holder by % of total assets is "TEKLA HEALTHCARE INVESTORS", owning 175.82K shares, compromising 0.21% of its total assets.

Milestone Pharmaceuticals Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 2440-9.09%
31 Mar, 24444.76%
31 Dec, 23425.00%
30 Sep, 2340-18.37%
30 Jun, 2349-3.92%
31 Mar, 2351-13.56%
31 Dec, 2259-3.28%
30 Sep, 226174.29%
30 Jun, 223520.69%
31 Mar, 222916.00%
31 Dec, 2125-13.79%
30 Sep, 2129-3.33%
30 Jun, 2130-18.92%
31 Mar, 213712.12%
31 Dec, 203313.79%
30 Sep, 202938.10%
30 Jun, 202140.00%
31 Mar, 2015-37.50%
31 Dec, 19249.09%
30 Sep, 1922-8.33%
30 Jun, 1924-

As of 30 Jun 24, 40 institutions are holding Milestone Pharmaceuticals's shares, representing a decrease of -9.09% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2430,157,942-3.81%
31 Mar, 2431,351,69976.28%
31 Dec, 2317,784,737-8.16%
30 Sep, 2319,364,922-5.45%
30 Jun, 2320,480,089-4.80%
31 Mar, 2321,512,503-10.74%
31 Dec, 2224,101,6339.76%
30 Sep, 2221,958,1565.44%
30 Jun, 2220,825,690-0.94%
31 Mar, 2221,024,3704.07%
31 Dec, 2120,201,4171.49%
30 Sep, 2119,905,807-0.90%
30 Jun, 2120,087,041-0.63%
31 Mar, 2120,213,926-1.31%
31 Dec, 2020,482,27433.13%
30 Sep, 2015,385,48758.59%
30 Jun, 209,701,6325.11%
31 Mar, 209,230,018-35.80%
31 Dec, 1914,376,98110.00%
30 Sep, 1913,069,429-0.09%
30 Jun, 1913,080,834-

Milestone Pharmaceuticals (MIST) has 30.16M shares outstanding as of 30 Jun 24, down -3.81% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2460.13%1.13%
31 Mar, 2472.99%4.26%
31 Dec, 2341.39%2.03%
30 Sep, 2345.10%1.97%
30 Jun, 2347.79%1.90%
31 Mar, 2350.20%1.58%
31 Dec, 2256.34%2.11%
30 Sep, 2251.68%2.13%
30 Jun, 2249.26%1.99%
31 Mar, 2249.77%2.17%
31 Dec, 2147.89%2.15%
30 Sep, 2147.19%2.03%
30 Jun, 2148.20%2.01%
31 Mar, 2149.00%1.01%
31 Dec, 2069.80%2.61%
30 Sep, 2051.67%3.33%
30 Jun, 2039.39%2.79%
31 Mar, 2037.60%0.45%
31 Dec, 1991.08%1.33%
30 Sep, 1982.80%0.84%
30 Jun, 1999.17%-

As of 30 Jun 24, Milestone Pharmaceuticals is held by 60.13% institutional shareholders, representing a 1.13% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2412-52.00%
31 Mar, 242556.25%
31 Dec, 231645.45%
30 Sep, 2311-52.17%
30 Jun, 232321.05%
31 Mar, 2319-54.76%
31 Dec, 224240.00%
30 Sep, 2230172.73%
30 Jun, 2211-42.11%
31 Mar, 221946.15%
31 Dec, 211344.44%
30 Sep, 219-25.00%
30 Jun, 2112-33.33%
31 Mar, 2118-18.18%
31 Dec, 202229.41%
30 Sep, 201730.77%
30 Jun, 201385.71%
31 Mar, 207-36.36%
31 Dec, 1911175.00%
30 Sep, 194-83.33%
30 Jun, 1924-

12 institutional shareholders have increased their position in MIST stock as of 30 Jun 24 compared to 25 in the previous quarter (a -52.00% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 24620.00%
31 Mar, 245-50.00%
31 Dec, 2310-28.57%
30 Sep, 231416.67%
30 Jun, 2312-25.00%
31 Mar, 2316100.00%
31 Dec, 228-33.33%
30 Sep, 221233.33%
30 Jun, 229350.00%
31 Mar, 222-33.33%
31 Dec, 213-72.73%
30 Sep, 211157.14%
30 Jun, 217-12.50%
31 Mar, 21833.33%
31 Dec, 206100.00%
30 Sep, 203200.00%
30 Jun, 201-85.71%
31 Mar, 20740.00%
31 Dec, 195-
30 Sep, 195-
30 Jun, 19--

6 institutional shareholders have reduced their position in MIST stock as of 30 Jun 24 compared to 5 in the previous quarter (a 20.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 2440-9.09%30,157,942-3.81%60.13%1.13%12-52.00%620.00%
31 Mar, 24444.76%31,351,69976.28%72.99%4.26%2556.25%5-50.00%
31 Dec, 23425.00%17,784,737-8.16%41.39%2.03%1645.45%10-28.57%
30 Sep, 2340-18.37%19,364,922-5.45%45.10%1.97%11-52.17%1416.67%
30 Jun, 2349-3.92%20,480,089-4.80%47.79%1.90%2321.05%12-25.00%
31 Mar, 2351-13.56%21,512,503-10.74%50.20%1.58%19-54.76%16100.00%
31 Dec, 2259-3.28%24,101,6339.76%56.34%2.11%4240.00%8-33.33%
30 Sep, 226174.29%21,958,1565.44%51.68%2.13%30172.73%1233.33%
30 Jun, 223520.69%20,825,690-0.94%49.26%1.99%11-42.11%9350.00%
31 Mar, 222916.00%21,024,3704.07%49.77%2.17%1946.15%2-33.33%
31 Dec, 2125-13.79%20,201,4171.49%47.89%2.15%1344.44%3-72.73%
30 Sep, 2129-3.33%19,905,807-0.90%47.19%2.03%9-25.00%1157.14%
30 Jun, 2130-18.92%20,087,041-0.63%48.20%2.01%12-33.33%7-12.50%
31 Mar, 213712.12%20,213,926-1.31%49.00%1.01%18-18.18%833.33%
31 Dec, 203313.79%20,482,27433.13%69.80%2.61%2229.41%6100.00%
30 Sep, 202938.10%15,385,48758.59%51.67%3.33%1730.77%3200.00%
30 Jun, 202140.00%9,701,6325.11%39.39%2.79%1385.71%1-85.71%
31 Mar, 2015-37.50%9,230,018-35.80%37.60%0.45%7-36.36%740.00%
31 Dec, 19249.09%14,376,98110.00%91.08%1.33%11175.00%5-
30 Sep, 1922-8.33%13,069,429-0.09%82.80%0.84%4-83.33%5-
30 Jun, 1924-13,080,834-99.17%-24---

Milestone Pharmaceuticals Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Dec 05, 2022Bharucha Davidofficer Chief Medical OfficerP-PurchaseBuy7,000$4.69$32.83K10,000
Dec 05, 2022Bharucha Davidofficer Chief Medical OfficerP-PurchaseBuy3,000$4.86$14.58K3,000

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Dec 05, 2022Bharucha Davidofficer Chief Medical OfficerP-PurchaseBuy7,000$4.69$32.83K10,000
Dec 05, 2022Bharucha Davidofficer Chief Medical OfficerP-PurchaseBuy3,000$4.86$14.58K3,000

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 17, 2024Saik Andrewdirector-A-AwardSell80,000$1.58$126.80K80,000
Jul 17, 2024Duty Stuartdirector-A-AwardSell80,000$1.58$126.80K80,000
Mar 24, 2023RTW INVESTMENTS, LP10 percent owner-J-OtherSell1,059,000-$1.06K3,256,102

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 17, 2024Saik Andrewdirector-A-AwardSell80,000$1.58$126.80K80,000
Jul 17, 2024Saik Andrew-Buy----
Jul 17, 2024Duty Stuartdirector-A-AwardSell80,000$1.58$126.80K80,000
Jul 17, 2024Duty Stuart-Buy----
Jun 09, 2023Wills Robert Jamesdirector-A-AwardBuy30,000$3.86$115.80K30,000
Jun 09, 2023TOMSICEK MICHAEL JOHNdirector-A-AwardBuy30,000$3.86$115.80K30,000
Jun 09, 2023Pasternak Richard Cdirector-A-AwardBuy30,000$3.86$115.80K30,000
Jun 09, 2023Liebert Debra K.director-A-AwardBuy30,000$3.86$115.80K30,000
Jun 09, 2023Giles Lisa M.director-A-AwardBuy30,000$3.86$115.80K30,000
Jun 09, 2023Fischer Seth H. Z.director-A-AwardBuy30,000$3.86$115.80K30,000
Mar 24, 2023RTW INVESTMENTS, LP10 percent owner-J-OtherSell1,059,000-$1.06K3,256,102
Mar 23, 2023Fischer Seth H. Z.director-A-AwardBuy42,000$3.45$144.90K42,000
Mar 23, 2023Fischer Seth H. Z.director Buy----
Feb 17, 2023Muller Lorenzofficer Chief Commercial OfficerA-AwardBuy105,000$3.59$376.95K105,000
Feb 17, 2023Nelson Jeffrey Edwardofficer Chief Operating OfficerA-AwardBuy105,000$3.59$376.95K105,000
Feb 17, 2023Hasija Amitofficer CFO & EVP of Corp. DevelopmentA-AwardBuy130,000$3.59$466.70K130,000
Feb 17, 2023Bharucha Davidofficer Chief Medical OfficerA-AwardBuy185,000$3.59$664.15K185,000
Feb 17, 2023Oliveto Josephdirector, officer President and CEOA-AwardBuy360,000$3.59$1.29M360,000
Dec 05, 2022Bharucha Davidofficer Chief Medical OfficerP-PurchaseBuy7,000$4.69$32.83K10,000
Dec 05, 2022Bharucha Davidofficer Chief Medical OfficerP-PurchaseBuy3,000$4.86$14.58K3,000

The last insider sell of Milestone Pharmaceuticals's stock was made by Saik Andrew on Jul 17 2024, selling 80,000 shares at $1.58 per share (valued at $126.80K). The last insider buy of MIST was made by Bharucha David on Dec 05 2022, buying 7,000 shares at $4.69 per share (worth $32.83K).

Milestone Pharmaceuticals Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024-2-
Q2 20236--
Q1 202361600.00%
Q4 20227--
Q3 2022132650.00%
Q2 202255100.00%
Q1 20225--
Q2 20218--
Q1 20215--
Q4 20203--
Q3 20202366.67%
Q2 2020132650.00%
Q1 20208--
Q4 2019153500.00%
Q3 20192--
Q2 2019154334.88%

0 total buy trades, and 2 total sell trades (buy/sell ratio of 0.00%) were made by Milestone Pharmaceuticals's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024---
Q2 2023---
Q1 2023---
Q4 20227--
Q3 202222100.00%
Q2 20221--
Q1 2022---
Q2 20212--
Q1 2021---
Q4 20201--
Q3 20201250.00%
Q2 2020---
Q1 20204--
Q4 20191011000.00%
Q3 2019---
Q2 20194--

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Milestone Pharmaceuticals's stocks.

Milestone Pharmaceuticals Peer Ownership


TickerCompany
GRCLGracell Biotechnologies Inc.
XFORX4 Pharmaceuticals, Inc.
CGEMCullinan Oncology, Inc.
IVAInventiva S.A.
IKTInhibikase Therapeutics, Inc.
DAWNDay One Biopharmaceuticals, Inc.
SCPHscPharmaceuticals Inc.
HOOKHOOKIPA Pharma Inc.
SPROSpero Therapeutics, Inc.
MCRBSeres Therapeutics, Inc.
TERNTerns Pharmaceuticals, Inc.
BOLTBolt Biotherapeutics, Inc.
ONCYOncolytics Biotech Inc.
GLUEMonte Rosa Therapeutics, Inc.
NAMSNewAmsterdam Pharma Company N.V.
DMACDiaMedica Therapeutics Inc.
NLTXNeurogene Inc.
CHRSCoherus BioSciences, Inc.
LIFEaTyr Pharma, Inc.
CMPXCompass Therapeutics, Inc.

MIST Ownership FAQ


Milestone Pharmaceuticals is owned by institutional shareholders (60.13%), insiders (0.69%), and public (39.18%). The largest institutional shareholder of Milestone Pharmaceuticals is BLACKROCK INC. (9.91% of total shares) and the top mutual fund owner is TEKLA HEALTHCARE INVESTORS (0.21% of total shares).

Milestone Pharmaceuticals's major institutional shareholders are BLACKROCK INC., RTW INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC, ALTA FUNDAMENTAL ADVISERS LLC, and LION POINT CAPITAL, LP. The top five shareholders own together 31.85% of the company's share outstanding.

As of Jun 2024, there are 40 institutional shareholders of Milestone Pharmaceuticals.

BLACKROCK INC owns 4.97M shares of Milestone Pharmaceuticals, representing 9.91% of the company's total shares outstanding, valued at $6.56M (as of Jun 2024).

As of Jun 2024, RTW INVESTMENTS, LP holds 3.26M shares of Milestone Pharmaceuticals (MIST), compromising 6.49% of the company, valued at $4.3M.

MILLENNIUM MANAGEMENT LLC is the third largest holder of Milestone Pharmaceuticals. The company owns 2.75M of the company's shares outstanding (worth $3.66M).